Baudax Bio, Inc.
490 Lapp Rd.
Malvern, Pennsylvania 19355
October 1, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Baudax Bio, Inc. |
Registration Statement on Form S-3
Filed August 10, 2020 (File No. 333-243488)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Baudax Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-243488) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:01 PM, eastern time, on October 2, 2020, or as soon as thereafter as is practicable.
Please contact Rachael M. Bushey, Esq. of Troutman Pepper Hamilton Sanders LLP, counsel to the Company, at (215) 981-4331 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[Remainder of the page intentionally left blank]
Very truly yours,
| BAUDAX BIO, INC. | ||
| By: | /s/ Gerri A. Henwood | |
| Name: Gerri A. Henwood | ||
| Title: Chief Executive Officer | ||
Baudax Bio, Inc. — Acceleration Letter